Bullet points of Novo Nordisk's Monlunabant Data Drags Stocks Of Smaller Players
- Novo Nordisk's monlunabant achieved a weight loss of 7.1 kg compared to 0.7 kg with a placebo after 16 weeks of treatment.
- The company's shares are down 41% at $3.24, and Corbus Pharmaceuticals' shares are down 59.4% at $21.00.
- Analysts are maintaining their ratings for Corbus Pharmaceuticals, with Wedbush and B. Riley Securities lowering their price targets.
- Skye Bioscience is conducting a Phase 2 trial in obesity for its drug nimacimab, which is expected to provide interim and topline data in 2025.
finance.yahoo.com / Yahoo! Finance by Layer3.news
npub12r…aag2f
2024-09-20 20:11:34
in reply to nevent1q…cmrg
Author Public Key
npub12r47d08z9kyana2h8lp6ky7e2v9fpkvku7zaecrqyq8ylg83lynsqaag2fPublished at
2024-09-20 20:11:34Event JSON
{
"id": "209c7f158df0d8e022bb53e4bb2265c07fa0ec7a7ca636121e1786abf488b6d3",
"pubkey": "50ebe6bce22d89d9f5573fc3ab13d9530a90d996e785dce060200e4fa0f1f927",
"created_at": 1726863094,
"kind": 1,
"tags": [
[
"subject",
"Bullet points of Novo Nordisk's Monlunabant Data Drags Stocks Of Smaller Players"
],
[
"p",
"50ebe6bce22d89d9f5573fc3ab13d9530a90d996e785dce060200e4fa0f1f927"
],
[
"e",
"74c9245d0ff487a37df3ec870af927884be45f85041e6d776d8696c3fd7923b4",
"wss://articles.layer3.news",
"root"
]
],
"content": "Bullet points of Novo Nordisk's Monlunabant Data Drags Stocks Of Smaller Players\n- Novo Nordisk's monlunabant achieved a weight loss of 7.1 kg compared to 0.7 kg with a placebo after 16 weeks of treatment.\n- The company's shares are down 41% at $3.24, and Corbus Pharmaceuticals' shares are down 59.4% at $21.00.\n- Analysts are maintaining their ratings for Corbus Pharmaceuticals, with Wedbush and B. Riley Securities lowering their price targets.\n- Skye Bioscience is conducting a Phase 2 trial in obesity for its drug nimacimab, which is expected to provide interim and topline data in 2025.\n",
"sig": "2f685611fae297963d0df736d4428acc13a6e1a6f938ac37a7fb7bd25d0557c04aa058069ea33b78a26fd6ac0445b86294f84cd3d2387eeb17bec58563a88bb5"
}